Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Alternatives International

This article was originally published in The Tan Sheet

Executive Summary

Sales decline 30.8% in the fiscal third quarter to $13.1 mil. from $19 mil. last year. The company reports a net loss for the quarter of $4.3 mil. San Marcos, Calif.-based NAI incurred charges of $6.6 mil. during the quarter relating to the firm's decision not to occupy its new Carlsbad, Calif. facility, inventory write-down and severance expenses. NAI will sublease the Carlsbad plant and focus production in its San Marcos and Vista, Calif. facilities. NAI points to the "reduction in market demand for several herbal products" that caused the firm to "write down the value of our inventories." NAI previously announced the opening of a plant in Lugano, Switzerland ("The Tan Sheet" Feb. 15, p. 7)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel